CIK 0001604464
- Non-accelerated filer
- Smaller reporting company
Atara Biotherapeutics, Inc.
Sign in to watch- Ticker
- ATRA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 460920988
- Phone
- +1 805-623-4211
- Business address
- 1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA, 91320
- Open-market buys, last 90 days
- $999,994
- in 1 filing
- Open-market sales, last 90 days
- $39,368
- in 1 filing
Net +$960,625. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 3 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-02-16 | Clark Mitchall G. Chief R & QA Officer | Exercise or conversion · Restricted Stock Unites | −7,211 | 62,500 | ||
| 2016-02-16 | Ciechanover Isaac E. Chief Executive Officer | Exercise or conversion | +5,908 | 217,321 | ||
| 2016-02-16 | Ciechanover Isaac E. Chief Executive Officer | Exercise or conversion · Restricted Stock Units | −5,908 | 45,292 | ||
| 2016-02-16 | MCGRATH JOHN Chief Financial Officer | Exercise or conversion | +2,804 | 82,017 | ||
| 2016-02-16 | MCGRATH JOHN Chief Financial Officer | Exercise or conversion | +7,697 | 89,714 | ||
| 2016-02-16 | MCGRATH JOHN Chief Financial Officer | Sale | −6,000 | $15.49 | $93K | 83,714 |
| 2016-02-16 | MCGRATH JOHN Chief Financial Officer | Exercise or conversion · Restricted Stock Units | −2,804 | 12,153 | ||
| 2016-02-16 | MCGRATH JOHN Chief Financial Officer | Exercise or conversion · Restricted Stock Units | −7,697 | 59,014 | ||
| 2016-02-09 | Haqq Christopher Chief Medical Officer | Grant or award | +55,900 | 297,619 | ||
| 2016-02-09 | Clark Mitchall G. Chief R & QA Officer | Grant or award | +42,857 | 77,642 | ||
| 2016-02-09 | Turner Heather D VP, General Counsel & Sec. | Grant or award | +48,857 | 48,857 | ||
| 2016-02-09 | Soffer Gad Chief Operating Officer | Grant or award | +48,447 | 120,460 | ||
| 2016-02-09 | MCGRATH JOHN Chief Financial Officer | Grant or award | +42,857 | 79,213 | ||
| 2016-02-09 | Ciechanover Isaac E. Chief Executive Officer | Grant or award | +163,973 | 211,413 | ||
| 2016-01-14 | Ciechanover Isaac E. Chief Executive Officer | Sale | −1,200 | $20.07 | $24K | 379,211 |
| 2016-01-13 | Ciechanover Isaac E. Chief Executive Officer | Sale | −1,200 | $20.32 | $24K | 380,411 |
| 2016-01-04 | SEIDENBERG BETH C Director | Grant or award · Non-Qualified Stock Option (Right to Buy) | +10,500 | 10,500 | ||
| 2016-01-04 | HEIDEN WILLIAM K Director | Grant or award · Non-Qualified Stock Option (Right to Buy) | +10,500 | 10,500 | ||
| 2016-01-04 | MARCUS JOEL S Director | Grant or award · Non-Qualified Stock Option (Right to Buy) | +10,500 | 10,500 | ||
| 2016-01-04 | Fust Matthew K Director | Grant or award · Non-Qualified Stock Option (Right to Buy) | +10,500 | 10,500 |
Page 56 of 71 · 1,403 trades